July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Lack of overt pathology in a K42E knock-in mouse model of retinitis pigmentosa (RP59)
Author Affiliations & Notes
  • Steven J Fliesler
    Research Service, VA Western NY Healthcare System, Buffalo, NY, New York, United States
    Ophthalmology, Biochemistry and Neuroscience Program, SUNY-University at Buffalo, Buffalo, New York, United States
  • Pravallika Kotla
    Optometry and Vision Science, UAB School of Optometry, Birmingham, Alabama, United States
  • Sriganesh Ramachandra Rao
    Research Service, VA Western NY Healthcare System, Buffalo, NY, New York, United States
    Ophthalmology, Biochemistry and Neuroscience Program, SUNY-University at Buffalo, Buffalo, New York, United States
  • Steven J. Pittler
    Optometry and Vision Science, UAB School of Optometry, Birmingham, Alabama, United States
  • Footnotes
    Commercial Relationships   Steven Fliesler, None; Pravallika Kotla, None; Sriganesh Ramachandra Rao, None; Steven Pittler, None
  • Footnotes
    Support  NEI/NIH (1R01 EY029341; SJP, SJF); NIH/NCATS (1UL1 TR001412-03; SJF); Fight for Sight Summer Student Fellowships (SRR); VA facilities and resources (SRR, SJF); NIH P30 grant (EY003039; SJP).
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 450. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Steven J Fliesler, Pravallika Kotla, Sriganesh Ramachandra Rao, Steven J. Pittler; Lack of overt pathology in a K42E knock-in mouse model of retinitis pigmentosa (RP59). Invest. Ophthalmol. Vis. Sci. 2019;60(9):450.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A K42E point mutation in the dehydrodolichyl diphosphate synthase (DHDDS) gene causes a recessive form of retinitis pigmentosa (RP59). We created a novel mouse model of RP59 to study its underlying pathophysiology mechanism.

Methods : CRISPR gRNA was generated to create a double strand break in the DHDDS locus to promote introduction of a single stranded oligodeoxynucleotide carrying the K42E mutation and a second silent DNA polymorphism to eliminate the PAM recognition site required for cleavage by CAS9. Mice (C57BL6/J) heterozygous for the K42E mutation were thus generated and crossed to generate K42E/K42E homozygous mice (confirmed by PCR DNA sequencing). Three potential F0 founder pups were generated from 13 F0 mice, and an F0 founder was verified by DNA sequence analysis. Optical coherence tomography (OCT) was performed at 1 and 3 months (K42E/+, N=6) and 1, 3, and 8 months (K42E/K42E; N=3-7) to assess retinal structure, in comparison with age-matched wild type controls.

Results : Three potential K42E F0 founder pups were generated from 13 F0 mice, and an F0 founder was verified by DNA sequence analysis. OCT analyses were performed on 4 generations of knock-in mice. K42E mutant mouse retinas from all generations exhibited normal cell layer stratification, with no evidence of retinal degeneration or cell loss over the time course examined. OCT results were confirmed by correlative histological analysis.

Conclusions : Despite successful generation of homozygous mutant mice harboring the K42E DHDDS mutation associated with RP59, no retinal degeneration was observed. These results are in contrast to a previous report, using another K42E mouse model (Li Y, et al. ARVO 2014), which found retinal degeneration by 3 postnatal months. The reasons for this discrepancy remain unclear. The RP59 mechanism of retinal degeneration may be more complicated than simple DHDDS loss-of-function.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×